Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-26T05:54:13.510Z Has data issue: false hasContentIssue false
  • English
  • Français

An Investigation into the Therapeutic Action of Hydroxyzine (Atarax) in the Treatment of Nervous Disorders and the Control of the Tobacco-Habit

Published online by Cambridge University Press:  08 February 2018

G. C. Turle
G. C. Turle*
Affiliation:
St. Augustine's Hospital, Chartham, Kent
Get access Rights & Permissions [Opens in a new window]

Extract

Hydroxyzine hydrochloride (Atarax, UCB 4492) is a tranquillizer which has attracted much interest in the United States, where it has undergone a series of clinical trials with encouraging results. In order to test the claims of American investigators a trial of hydroxyzine was made on a group of psychotic and psychoneurotic patients in a large mental hospital. The effectiveness of hydroxyzine in controlling the tobacco habit was also tested by using volunteer nurses at the hospital. Their observations provided useful information on the subjective action and side effects of the drug. A small number of young children attending a local child guidance clinic were also included in the clinical trial.

Type
Original Articles
Information
Journal of Mental Science , Volume 104 , Issue 436 , July 1958 , pp. 826 - 833
Copyright
Copyright © Royal College of Psychiatrists, 1958 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bayart, J., “Treatment of nervous conditions in infancy with hydroxyzine”, July, 1956. International Pediatric Congress, Copenhagen. Google Scholar
Farah, L., “Preliminary study on the use of hydroxyzine in psychosomatic affections”, June, 1956. International Record of Medicine and A.P. Clinics. Google Scholar
Fouks, , et al., “Notes sur l'utilisation en psychiatrie d'un nouveau neuroleptiquè”, Ann. Méd. Psychol., 1956, 1, 605. April.Google Scholar
Robinson, H., “Hydroxyzine (Atarax) in Dermatological Therapy”, J. Amer. Med. Ass., 1956, 161, 7.CrossRefGoogle Scholar
Segal, L. J., “A clinical trial with hydroxyzine (Atarax) on a group of maladjusted educationally subnormal children”, J. Ment. Sci., July, 1957.CrossRefGoogle Scholar
Settel, E., “Clinical observations on the use of hydroxyzine (Atarax) in tension states”.Google Scholar
Shalowitz, M., “Hydroxyzine a new therapeutic agent for senile anxiety states”, Geriatrics, July, 1956.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.